BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20067549)

  • 21. Wireless upper esophageal monitoring for laryngopharyngeal reflux (LPR).
    Friedman M; Schalch P; Vidyasagar R; Kakodkar KA; Mazloom N; Joseph NJ
    Otolaryngol Head Neck Surg; 2007 Sep; 137(3):471-6. PubMed ID: 17765778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laryngopharyngeal reflux: current concepts and questions.
    Gupta R; Sataloff RT
    Curr Opin Otolaryngol Head Neck Surg; 2009 Jun; 17(3):143-8. PubMed ID: 19395970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laryngeal disorders in patients with gastroesophageal reflux disease.
    Farrokhi F; Vaezi MF
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):181-7. PubMed ID: 17557046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laryngopharyngeal reflux: diagnosis, treatment, and latest research.
    Campagnolo AM; Priston J; Thoen RH; Medeiros T; Assunção AR
    Int Arch Otorhinolaryngol; 2014 Apr; 18(2):184-91. PubMed ID: 25992088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
    Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
    Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laryngeal pseudosulcus as a predictor of laryngopharyngeal reflux.
    Hickson C; Simpson CB; Falcon R
    Laryngoscope; 2001 Oct; 111(10):1742-5. PubMed ID: 11801937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reflux-associated laryngitis and laryngopharyngeal reflux: a gastroenterologist's point of view.
    Hammer HF
    Dig Dis; 2009; 27(1):14-7. PubMed ID: 19439955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and management of laryngopharyngeal reflux disease.
    Mahieu HF; Smit CF
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):133-7. PubMed ID: 16728888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advantages of pH-impedance monitoring in gastroesophageal reflux and dysphagia investigations].
    Olivier F; Brossard E
    Rev Med Suisse; 2008 Oct; 4(173):2103-6. PubMed ID: 18959079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The significance of laryngopharyngeal reflux in benign vocal mucosal lesions.
    Chung JH; Tae K; Lee YS; Jeong JH; Cho SH; Kim KR; Park CW; Han DS
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3):369-73. PubMed ID: 19716016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparison of an empiric proton pump inhibitor trial vs 24-hour double-probe Ph monitoring in laryngopharyngeal reflux.
    Bilgen C; Ogüt F; Kesimli-Dinç H; Kirazli T; Bor S
    J Laryngol Otol; 2003 May; 117(5):386-90. PubMed ID: 12803789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laryngopharyngeal symptoms and gastroesophageal reflux disease.
    Rouev P; Chakarski I; Doskov D; Dimov G; Staykova E
    J Voice; 2005 Sep; 19(3):476-80. PubMed ID: 15936924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A more than 10-year prospective, follow-up study of esophageal and pharyngeal acid exposure, symptoms and laryngeal findings in healthy, asymptomatic volunteers.
    Andersson O; Möller RY; Finizia C; Ruth M
    Scand J Gastroenterol; 2009; 44(1):23-31. PubMed ID: 18759152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy.
    Zerbib F; Roman S; Ropert A; des Varannes SB; Pouderoux P; Chaput U; Mion F; Vérin E; Galmiche JP; Sifrim D
    Am J Gastroenterol; 2006 Sep; 101(9):1956-63. PubMed ID: 16848801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medical therapy of reflux laryngitis.
    Johnson DA
    J Clin Gastroenterol; 2008; 42(5):589-93. PubMed ID: 18427287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of laryngopharyngeal reflux disease.
    Celik M; Ercan I
    Curr Opin Otolaryngol Head Neck Surg; 2006 Jun; 14(3):150-5. PubMed ID: 16728891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.